NCT00247078View on ClinicalTrials.gov

The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

December 31, 2006

Conditions
ArachnidismLatrodectism
Interventions
BIOLOGICAL

widow spider antivenom

3 vials of antivenom capable of neutralizing 600 LD50 of L. mactans

BIOLOGICAL

Placebo

Trial Locations (1)

80204

Denver Health and Hospital Authority, Denver

All Listed Sponsors
collaborator

Rocky Mountain Poison and Drug Center

UNKNOWN

lead

Instituto Bioclon S.A. de C.V.

INDUSTRY

NCT00247078 - The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism | Biotech Hunter | Biotech Hunter